One year since the outbreak emerged in Wuhan, China says it has vaccinated nearly one million people against Covid-19. FRANCE 24 correspondent Charles Pellegrin says while the vaccines have yet to be fully approved for market, authorities have granted permission for their limited use on selected groups of the population.
Tag Archives: Health
Covid-19: ‘When Will The U.S. Get The Vaccine?’
The initial doses of Pfizer and BioNTech’s Covid-19 vaccines could go out next month, if the FDA grants emergency authorization. There are also three other promising vaccine candidates in the pipeline from AstraZeneca, Moderna, and Johnson & Johnson. The process of distributing the vaccine to the 330 million people living in the U.S., however, could prove a logistical challenge. Here’s a look at how the federal government plans to do it.
Infographic: ‘Benefits Of Probiotics’ On Exercise Performance & Health
Post Covid: “The Future Of Elderly Care’ (Video)
Across the rich world around half of covid-19 deaths have been in care homes. Countries need to radically rethink how they care for their elderly—and some innovative solutions are on offer.
Covid-19 Podcast: New Studies On Transmission
In this audio interview conducted on November 25, 2020, the editors look at new studies of disease transmission in closed environments and provide updates on convalescent plasma and hydroxychloroquine.
Covid-19: How The U.S. Will Roll Out Vaccine (Video)
The worsening pandemic continues to mean millions of Americans out of work. For older employees in particular, this kind of long-term unemployment can represent the end of a career — especially when they may be facing age discrimination and bias. Economics correspondent Paul Solman looks at the problem as part of his series Unfinished Business.
Infographic: ‘How Covid-19 Damages Sense Of Smell’
Covid-19: ‘Ventilation Key To Limiting Spread’ (Video)
As the weather gets colder and people head indoors, the risk of catching Covid-19 is rising. WSJ explains why air ventilation and filtration are one of our biggest defenses against the coronavirus this winter.
Illustration: Nick Collingwood/WSJ
New Survey: 58% Of Older Adults Are ‘Likely’ To Get A Covid-19 Vaccine (Nov ’20)
When asked how likely they would be to get a COVID-19 vaccine when available and if no cost to them, 58% of older adults indicated they would be likely to get a COVID-19 vaccine (33% very likely, 25% somewhat likely), 28% said they were unlikely (11% somewhat unlikely, 17% very unlikely), and 14% were unsure or did not know.
About two in three older adults (63%) indicated they received a flu shot last flu season. Seven in ten either received one since August 2020 (34%) or intended to get one this flu season (38%). Nearly half of adults age 50–80 (49%) believed that getting a flu vaccine is more important this year compared to other years, 44% said it is just as important, and 7% said it was less important.
Interest in getting a COVID-19 vaccine was more common among those age 65–80 compared with those 50–64 (63% vs. 54%), men compared with women (64% vs. 52%), and Whites compared with Hispanics and Blacks (63% vs. 51% vs. 40%). Individuals who lived with others, had higher household incomes, or had more education were also more likely to report they would get a COVID vaccine.
Half of adults age 50–80 (52%) said they personally knew someone who had COVID-19, and 2% reported having had it themselves. One in five older adults (19%) indicated they personally knew someone who died from COVID-19. The likelihood of getting a COVID-19 vaccine did not differ based on whether respondents knew someone who had COVID-19 or who died from it.
In deciding whether to get a COVID-19 vaccine, older adults rated the following as very important: how well it works (80%), their own research (56%), and if it was recommended by their doctor (52%), public health officials (42%), or family and friends (13%). Cost was rated as very important by 30% of older adults.
Boomers Daily 